8 insiders reported 44 Form 4 transactions for UroGen Pharma Ltd. (URGN) over the past 18 months (most recent 2026-09-09). Recent activity: Schoenberg Mark (Chief Medical Officer) Buy 1,667 shares, Smith Jason Drew (General Counsel) Buy 3,334 shares, Schoenberg Mark (Chief Medical Officer) Sell 871 shares, Smith Jason Drew (General Counsel) Sell 1,519 shares, Robinson James A. Jr. (Director) Buy 2,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | Buy | 1,667 | $0 |
| 2026-09-09 | Smith Jason Drew | General Counsel | Buy | 3,334 | $0 |
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | Sell | 871 | $37,383 |
| 2026-09-09 | Smith Jason Drew | General Counsel | Sell | 1,519 | $64,618 |
| 2026-08-28 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-08-24 | Schoenberg Mark | Chief Medical Officer | Sell | 60,677 | $2.9M |
| 2026-07-10 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $400,000 |
| 2026-06-24 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $350,100 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Sell | 5,222 | $142,561 |
| 2026-05-27 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-05-11 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $300,000 |
| 2026-02-27 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 5,500 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 2,654 | $52,257 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 3,333 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 1,608 | $31,662 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 6,667 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 3,217 | $63,343 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,844 | $36,308 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,843 | $36,289 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 3,686 | $72,577 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 3,334 | $0 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 3,333 | $0 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 6,666 | $0 |
Source: SEC Form 4 filings · as of 2026-09-09